MetLife Investment Management’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Buy |
15,208
+3,157
| +26% | +$26.2K | ﹤0.01% | 2424 |
|
|
2025
Q1 | $73.4K | Sell |
12,051
-3,625
| -23% | -$22.1K | ﹤0.01% | 2632 |
|
|
2024
Q4 | $99.1K | Buy |
+15,676
| New | +$99.1K | ﹤0.01% | 2627 |
|
|
2024
Q3 | – | Sell |
-4,526
| Closed | -$27.7K | – | 2872 |
|
|
2024
Q2 | $27.7K | Sell |
4,526
-5,153
| -53% | -$31.5K | ﹤0.01% | 2854 |
|
|
2024
Q1 | $108K | Hold |
9,679
| – | – | ﹤0.01% | 2499 |
|
|
2023
Q4 | $109K | Hold |
9,679
| – | – | ﹤0.01% | 2572 |
|
|
2023
Q3 | $72.7K | Hold |
9,679
| – | – | ﹤0.01% | 2746 |
|
|
2023
Q2 | $85.5K | Buy |
+9,679
| New | +$85.5K | ﹤0.01% | 2778 |
|
|
2020
Q3 | – | Sell |
-11,329
| Closed | -$94.6K | – | 2313 |
|
|
2020
Q2 | $94.6K | Buy |
+11,329
| New | +$94.6K | ﹤0.01% | 2272 |
|